Trial Profile
Subcutaneous Injection of Botulinum Toxin A for At--Level Back Pain in Patients With Spinal Cord Injury
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 05 Apr 2019 Status changed from recruiting to discontinued.
- 07 May 2018 Planned End Date changed from 1 Jun 2018 to 1 Feb 2019.
- 07 May 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Feb 2019.